NCT06454227 Subcutaneous Lavage in Cesarean Section
| NCT ID | NCT06454227 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hadassah Medical Organization |
| Condition | Surgical Site Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-09-22 |
| Primary Completion | 2027-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2024-09-22 with a primary completion date of 2027-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if antiseptic washing prior to skin closure during cesarean section reduces rates of surgical site infection. intraoperative washing is a common practice in other surgical fields and several studies have shown efficacy in reducing postoperative infection rates. no randomized control trial has tested this intervention during cesarean section. The main questions we aim to answer are: Does subcutaneous antiseptic washing reduce the rates of surgical site infection? Does antiseptic washing improve scar healing? Does antiseptic washing reduce hospital stay, postpartum fever rates and readmission cases? Researchers will compare subcutaneous antiseptic washing to no intervention to see if surgical site infection rates reduce Participants will: consent to participate in the trial Visit the postpartum clinic 30 days after surgery
Eligibility Criteria
Inclusion Criteria: * pregnant women undergoing cesarean delivery Exclusion Criteria: * pregnant women undergoing vaginal delivery
Frequently Asked Questions
Who can join the NCT06454227 clinical trial?
This trial is open to female participants only, studying Surgical Site Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06454227 currently recruiting?
Yes, NCT06454227 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hadassah Medical Organization to inquire about joining.
Where is the NCT06454227 trial being conducted?
This trial is being conducted at Jerusalem, Israel.
Who is sponsoring the NCT06454227 clinical trial?
NCT06454227 is sponsored by Hadassah Medical Organization. The trial plans to enroll 600 participants.